Condition 101 About Reticuloendotheliosis

What are the alternative names for Reticuloendotheliosis?

  • Reticuloendotheliosis, X-linked

Latest Advances On Reticuloendotheliosis

  • Condition: Extensive Meningeal Juvenile Xanthogranuloma After Treatment of Langerhans Cell Histiocytosis (LCH) in Child
  • Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
  • Treatment Used: Unrelated Cord Blood Transplantation (uCBT)
  • Number of Patients: 1
  • Published —
This case report describes a child with Langerhans cell histiocytosis (LCH) treated with chemotherapy who developed juvenile xanthogranuloma (nodules; JXG) treated with prednisolone, radiotherapy, chemotherapy, unrelated cord blood transplantation (u-CBT), infliximab, and dexamethasone.
  • Condition: Adult Langerhans Cell Histiocytosis
  • Journal: BMC cancer
  • Treatment Used: Methotrexate and Cytosine
  • Number of Patients: 36
  • Published —
The study researched the safety and effectiveness of methotrexate and cytosine for treating adult langerhans cell histiocytosis.

Clinical Trials For Reticuloendotheliosis

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Biological
  • Participants: 8
  • Start Date: August 2021
Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological
  • Participants: 40
  • Start Date: November 18, 2020
A Phase 1 Trial to Evaluate the Safety of Single Agent Flotetuzumab in Advanced CD123-Positive Hematological Malignancies